Literature DB >> 2584214

The carboxyl terminus of the chicken alpha 3 chain of collagen VI is a unique mosaic structure with glycoprotein Ib-like, fibronectin type III, and Kunitz modules.

P Bonaldo1, A Colombatti.   

Abstract

The primary amino acid sequence of the carboxyl-terminal portion of the alpha 3 chain of chick type VI collagen as deduced from the nucleotide sequence is reported. This carboxyl-terminal segment is not present in the alpha 1 and alpha 2 chains of chick type VI collagen and is specific for a mosaic region with extensive similarities to several other proteins. This unique segment, beginning with a stretch (73 residues) very rich in serine and threonine, is preceded by sequences analogous to the platelet glycoprotein Ib. This region is followed by one segment that closely resembles the type III domains of fibronectin. At the end of the sequence, there is a 58-residue motif very similar to sequences characteristic of the Kunitz-type proteinase inhibitors. The present findings and our recent observation that the alpha 3(VI) chain contains 11 repeats similar to type A repeats of von Willebrand factor raise interesting questions about the peculiar mosaic structure and the multiple functions that this unique collagen might play in growth and remodeling of connective tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2584214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Molecular composition of type VI collagen. Evidence for chain heterogeneity in mammalian tissues and cultured cells.

Authors:  C M Kielty; R P Boot-Handford; S Ayad; C A Shuttleworth; M E Grant
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Structure of the human hexabrachion (tenascin) gene.

Authors:  J R Gulcher; D E Nies; M J Alexakos; N A Ravikant; M E Sturgill; L S Marton; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.

Authors:  J H Rand; N D Patel; E Schwartz; S L Zhou; B J Potter
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Cloning of alpha 2 chain of type VI collagen and expression during mouse development.

Authors:  A Ibrahimi; B Bertrand; S Bardon; E Z Amri; P Grimaldi; G Ailhaud; C Dani
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

5.  von Willebrand factor binds to native collagen VI primarily via its A1 domain.

Authors:  M F Hoylaerts; H Yamamoto; K Nuyts; I Vreys; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

6.  Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.

Authors:  Ercan Demir; Patrizia Sabatelli; Valérie Allamand; Ana Ferreiro; Behzad Moghadaszadeh; Mohamed Makrelouf; Haluk Topaloglu; Bernard Echenne; Luciano Merlini; Pascale Guicheney
Journal:  Am J Hum Genet       Date:  2002-04-24       Impact factor: 11.025

7.  Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.

Authors:  R Z Zhang; T C Pan; R Timpl; M L Chu
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.

Authors:  A Nishiyama; X H Lin; W B Stallcup
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  Down Syndrome Related Muscle Hypotonia: Association with COL6A3 Functional SNP rs2270669.

Authors:  Arpita Dey; Krishnendu Bhowmik; Arpita Chatterjee; Pit Baran Chakrabarty; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Front Genet       Date:  2013-04-22       Impact factor: 4.599

10.  Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan.

Authors:  U Specks; U Mayer; R Nischt; T Spissinger; K Mann; R Timpl; J Engel; M L Chu
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.